MacuSight(TM) Initiates First Phase I Study Of Novel Ophthalmic Drug Candidate

Wed, 27 Sep 2006 12:00 PM EST

... MacuSight(TM), Inc., a developer of innovative therapeutics for the treatment of severe oculardiseases and conditions, today announced the initiation of a Phase I studyof its lead product candidate in patients with diabetic macular edema(DME). [click link for full article] ...